Cleary Gottlieb Steen & Hamilton LLP acted as counsel to the Company, and Sheppard Mullin Richter & Hampton LLP acted as counsel to the underwriters in connection with the offering.​​​​​​​ AnPac Bio-Medical Science Co., Ltd. announced the pricing and trading of its initial public offering. 1,333,360 American depositary shares (“ADSs”) were sold for a total […]

New York, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Univest Securities, LLC, a member of FINRA and SIPC, is a full-service investment bank and securities broker-dealer firm based in New York, today announced the pricing and trading of the initial public offering (“IPO”) for its client AnPac Bio-Medical Science Co., Ltd

SAN JOSE, Calif., Jan. 30, 2020 /PRNewswire/ — Anpac Bio-Medical Science Co., Ltd.  (“AnPac Bio” or the “Company”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that it has priced its initial public offering of 1,333,360 American depositary shares (“ADSs”) at […]

AnPac Bio-Medical Science, a Chinese provider of multi-cancer screening tests, announced terms for its US IPO on Friday. The Lishui, China-based company plans to raise $22 million by offering 1.7 million ADSs at a price range of $12 to $14. Insiders intend to purchase $2 million worth of shares in the offering. At the midpoint […]